Although there are reports that the addition of a
beta-lactamase inhibitor to
ampicillin or
amoxicillin greatly improves their in vitro activity against M.
tuberculosis, there are no written reports about the antituberculosis effects of
beta-lactamase inhibitors in combination with
cephalosporins against M.
tuberculosis. In this report, we have determined the minimal inhibitory concentrations (MIC) of 5
cephalosporins with or without combination with
beta-lactamase inhibitor against M.
tuberculosis strains isolated from patients before antituberculosis treatment and checked the production of
beta-lactamase by bacteria before this procedure. Four strains of M.
tuberculosis were contaminated during the experiment, and all the other 16 strains hydrolyzed the
nitrocefin disc, thus indicating a
beta-lactamase producer. The MICs of
cephalosporins alone against M.
tuberculosis were 200-400 micrograms/ml for
ceforanide, 100-400 micrograms/ml for
cephapirin, 400-1600 micrograms/ml for
cefamandole, 200-1600 micrograms/ml for
cefotaxime, and 800-1600 micrograms/ml for
ceftriaxone. After adding the equimolar concentrations of
sulbactam, the MICs were reduced to 100-200 micrograms/ml for
ceforanide, 12.5-100 micrograms/ml for
cephapirin, 100-400 micrograms/ml for
cefamandole, 25-200 micrograms/ml for
cefotaxime, and 100-800 micrograms/ml for
ceftriaxone. We concluded that
sulbactam enhanced the antituberculosis effect of
cephalosporins.